Premium
Management of gestational trophoblastic disease
Author(s) -
Goldstein Dp,
Hazel Gore,
Renata De
Publication year - 1993
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(93)90233-m
Subject(s) - gestational trophoblastic disease , disease , medicine , citation , gynecology , pregnancy , obstetrics , family medicine , gestation , computer science , library science , genetics , biology
Despite the potentially serious outcome of malignant GTD, most women with all forms of GTD can be successfully diagnosed and treated, with preservation of their normal reproductive function. It is important to manage hydatidiform mole properly in order to mini‐mize acute complications, identify malignant sequelae promptly, and begin therapy. It is important to individu‐alize therapy for women with malignant GTD based upon known risk factors, using less toxic therapy for patients with low‐risk disease and aggressive multiagent therapy for patients with high‐risk disease.